An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan

Saudi Medical Journal

Volumn 28, Issue 3, 2007, Pages 390-395

  Ahmad, Nasir ^a   Asgher, Muhammad ^b   Shafique, Muhammad ^a   Qureshi, Javed Anver ^a  

^a NATIONAL INSTITUTE FOR BIOTECHNOLOGY AND GENETIC ENGINEERING NIBGE   (Pakistan)

^b UNIVERSITY OF AGRICULTURE   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ENZYME ACTIVITY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOASSAY; INCIDENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PAKISTAN; POLYMERASE CHAIN REACTION; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING TEST; SENSITIVITY ANALYSIS; SEROLOGY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALANINE TRANSAMINASE; BLOOD DONORS; COHORT STUDIES; EARLY DIAGNOSIS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PAKISTAN; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; URBAN POPULATION;

EID: 34247217581     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from blood born non-A, non-B viral hepatitis genome. Science 1989; 244: 359-364.
2. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 6547-6549.
3. Anonymous. Hepatitis C; global prevalence. Weekly Epidemiol Record 1997; 72: 341-344
4. Koshy R, Inchauspe G. Evalutation of hepatitits C virus protein epitopes for vaccine development. Tibtech 1996; 14: 364-369.
5. Poel VD, Cupers HT, Reesink HW. Hepatitis C virus six years on. Lancet 1994; 344: 1475-1479.
6. Perrelli E, Manzin A, Paolucci S, Cioppi A, Brugla M, Muretto P, et al. Chronic liver disease and active hepatitis C virus infection in patients with antibodies to this virus. J Clin Pathol 1994; 47: 148-151.
7. Tisminetzky SG, Gerotto M, Ponstisso P, Chemello L, Baralle F, Alberti A. Genotyping of Hepatitis C virus in Italian patients with chronic hepatitis C. Int Hepatol Compl 1994; 42: 105-112.
8. Davis LG, Kuehl WM, Battey JF. Basic methods in molecular biology. 2nd ed. East Norwalk Connect: Appelton and Long; 1994. p. 159-161.
9. McOmish F, Yap PL, Dow BC, Follert AC, Seed C, Keeler AJ et al. Geographical distribution of hepatitis C virus genotypes in Blood Donors: an International Collaborative Survey. J Clin Microbiol 1994; 32: 884-892.
10. McOmish, F, Chan SW, Dow BC, Gillon J, Frame WD, Crawford RJ, et al. Detection of three types of hepatitis C virus in blood donor investigation of type specific differences in serological reaction and rate of Alanine aminotransferase abnormalities. Transfusion 1993; 33: 7-13.
11. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, et al. Classification of hepatitis C virus into six major types and a series of subtypes by phylogenic analysis of the NS-5 region. J Gen Virol 1993; 74: 2391-2399.
12. De-Medina M, Schiff ER. Hepatitis C: Diagnostic assays. Semin Liver Dis 1995; 15: 33-40.
13. Caldwell SH, Li X, Rourk RM, Millar A. Sosnowski KM, Sue M. Hepatitis C virus infection by polymerase chain reaction in alcoholic false positive ELISA result and the influence of infection on clinical prognostic score. Am J Gastroenterol 1993; 88: 1016-1021.
14. Fathalla SE, Aljama AA, Badawy MS, Sabry HS, Awad AO, Abulaziz AL, et al. Prevalence of hepatitis C virus infection in the Eastern Province of Saudi Arabia by RE-DNA 2nd-Generation and supplemental EIA tests. Saudi Med J 1994; 15: 281-285.
15. Kondili LA, Chionne P, Costantino A, Villano U, Lo Noce C, Pannozzo F, et al. Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut 2002; 50: 693-696.
16. Coltori M, Romano M, Persico M, Morisico F, Tuccillo C, Caporaso N. Hepatitis C virus RNA in serum and liver histology in asymptomatic anti-HCV positive subjects. Infection 1995; 23: 33-36.
17. Garson JA, Tuke PW, Makris M, Briggs M, Machin SJ, Piston FF, et al. Demonstration of viremic patterns in haemophiliacs treated with hepatitis C virus contaminated factor VIII concentrates. Lancet 1990; 336: 1022-1025.
18. Farci P, Alter HJ, Wong DC, Miller RH, Shih JW, Purcell RH, et al. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Eng J Med 1991; 325: 98-104.
19. Petrelli E, Manzin A, Paolucci S, Cioppi A, Brugia M, Muretto P, et al. Chronic liver disease and active hepatitis C virus infection in patients with antibodies to this virus. J Clin Pathol 1994; 47: 148-151.
20. Alberti A, Morsiea G, Chemelio L, Cavlleto D, Noventa F, Pontisso P, et al. Hepatitis C viremia and liver disease in symptom free individuals with anti-HCV. Lancet 1992; 340: 697-698.
21. Bastie A, Pawlotsky JM, Roudotthorard F, Dhameaue D. Hepatitis C virus infection and epidimiology. Biology 1995; 43: 674-680.
22. Green WK, Cheong MK, Ng V, Yap KW. Prevalence of hepatitis C variants in Southern Asia. J Virol 1995; 67: 211-215.
23. Gerotto M, Pontisso P, Giostra F, Francesconi R, Muratori L, Ballardini G, et al. Analysis of the hepatitis virus genome in patients with anti-LKM-1 autoantibodies. J Hepatol 1994; 21: 273-276.
24. Zeuzem S, Ruster B, Lee JH, Stripf T. Roth WK, Evaluation of a reverse hybridization assay for genotyping of hepatitis C virus. J Hepatol x ] 1995; 23; 654-661
25. Bernier L, illems B, Delage G, Murphy DG. Identification of numerous hepatitis C virus genotypes in Montreal, Canada. J Clin Microbiol 1996; 34: 2815-2818.
26. Gayowski T, Singh N, Marino IR, Vargas H, Wagener M, Wannstedt C, et al. Hepatitis C virus genotypes in liver transplant recipients; Impact on post-transplant recurrence, infections, response to interferon-alpha therapy and outcome. Transpl 1997; 64: 422-426.
27. Zali MR, Mayumi M, Raoufi M, Nowroozi A. Hepatitis C virus genotypes in the Islamic Republic of Iran: a preliminary study. East Mediterr Health J 2000; 6: 372-377.
28. Schulman S, Kinnman N, Lindmarker P, Von-Sydow MA. Randomized study of alpha-interferon plus ribavirin for 6 months or 12 months for the treatment of chronic hepatitis C in patients with bleeding disorders. Haemophilia 2002; 8: 129-135.
29. Djebbi A, Triki H, Bahri HO, Cheikh I, Sadraoui A, Ammar AB, et al. Genotypes of hepatitis C virus circulating in Tunisia. Epidemiol. Infection 2003; 130: 501-505.
30. Ravaggi A, Zonaro A, Marin MG, Puoti M, Albertini A, Cariani E. Distribution of viral genotypes in Italy determined by hepatitis C virus typing by DNA immunoassay. J Clin Microbiol 1994; 32: 2280-2284.
31. Chan CY, Lee SD, Hwang Sj, Lu RH, Lu CL, Lo KJ. Quantitative branched DNA assay and genotyping for hepatitis C virus RNA in Chinese patients with acute and chronic hepatitis C. J Infect Dis 1995; 171: 443-446.
32. Soetjipto HR, Lusida MI., Darmadi S, Soemarto AP, Ishido S, Katayama Y, et al. Differential prevalence of hepatitis C virus subtypes in healthy blood donors, patients on maintenance hemodialysis, and patients with hepatocellular-carcinoma in Surabaya, Indonesia. J Clin Microbiol 1996; 34: 2875-2880.
33. Re V, Lampe E, Yoshida CF, de-Oliveira JM, Lewis-Ximenez L, Spinsanti L, et al. Hepatitis C virus genotypes in Cordoba, Argentina. Unexpected high prevalence of genotype-2. Medicina 2003; 63: 205-210.
34. Das BR, Kundu B, Khandapkar R, Sahni S. Geographical distribution of hepatitis C virus genotypes in India. Indian J Pathol Microbiol 2002; 45: 323-328.
35. Nousbaum JB, Pol S, Gigou M, Lani SP, Brechot C. HCV genotype II is associated to liver cirrhosis, cancer and low response to interferon-alpha in European patients (abstract). Hepatol 1993; 18: 88A.
36. Chemello L, Alberti A, Rose K, Simmonds P. Hepatitis C serotype and response to interferon therapy. N Engl J Med 1994; 330: 146.
37. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, et al. Detection of Hepatitis C virus by polymerase chain reaction and response to interferon-alpfa therapy: relationship to genotypes of hepatitis C virus. Hepatol 1992; 16: 293-299.
38. Kanai K, Kako M, Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon. Lancet 1992; 339: 1543